Affiliation:
1. From the Departments of Hematology-Oncology, Pathology, and Virology, St Jude Children’s Research Hospital, Memphis, TN; and the Department of Pediatrics, University of Tennessee, Memphis College of Medicine, Memphis, TN.
Abstract
Abstract
In many different murine models, the immunogenicity of tumor cells can be increased by transduction with a range of immunostimulatory genes, inducing an immune response that causes regression of pre-existing unmodified tumor cells. To investigate the relevance of these animal models to pediatric malignancy, we used autologous unirradiated tumor cells transduced with an adenovirus-IL-2 to immunize 10 children with advanced neuroblastoma. In a dose-escalation study, we found that this tumor immunogen induced a moderate local inflammatory response consisting predominantly of CD4+ T lymphocytes, and a systemic response, with a rise in circulating CD25+and DR+ CD3+ T cells. Patients also made a specific antitumor response, manifest by an IgG antitumor antibody and increased cytotoxic T-cell killing of autologous tumor cells. Clinically, five patients had tumor responses after the tumor immunogen alone (one complete tumor response, one partial response, and three with stable disease). Four of these five patients were shown to have coexisting antitumor cytotoxic activity, as opposed to only one of the patients with nonresponsive disease. These results show a promising correlation between preclinical observations and clinical outcome in this disease, and support further exploration of the approach for malignant diseases of children.
© 1998 by The American Society of Hematology.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference48 articles.
1. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.;Fearon;Cell,1990
2. Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.;Blankenstein;J Exp Med,1991
3. Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors.;Asher;J Immunol,1991
4. Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of IL-2 cDNA.;Russell;Int J Cancer,1991
5. A new approach to the immunotherapy of bladder cancer using IL-2 gene transfer into MBT-2 cells.;Connor;Proc Annu Meet Am Assoc Cancer Res,1991
Cited by
87 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献